US OptionsDetailed Quotes
TGTX250502P32000
- 0.07
- +0.02+40.00%
15min DelayClose Apr 30 16:00 ET
0.21High0.06Low
0.21Open0.05Pre Close3 Volume4 Open Interest32.00Strike Price34.00Turnover276.85%IV29.84%PremiumMay 2, 2025Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type-0.0214Delta0.0062Gamma650.14Leverage Ratio-0.0692Theta0.0000Rho-13.92Eff Leverage0.0015Vega
TG Therapeutics Stock Discussion
Game-Changing MS Treatment? BRIUMVI Single-Dose Trial Reveals Breakthrough Potential
Game-Changing MS Treatment: BRIUMVI Reveals Exceptional Real-World Safety Profile
Medical Journals Reveal Breakthrough: BRIUMVI Succeeds Where Other MS Treatments Fall Short
How TG Therapeutics Transformed from Clinical-Stage to Profitable Biotech with 250% Revenue Growth
Can BRIUMVI Succeed Where Other MS Treatments Failed? New Clinical Data Reveals Promising Results
Larger Image: tradingview.com...
$TG Therapeutics (TGTX.US)$
No comment yet